Q5Y-25357-61898
4 vaccinations
3 coded responses
27 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 940 / CA
- Registered
- 2021-08-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-24
Dose 1 — Pfizer-BioNTech
-
2021-04-21
Dose 2 — Pfizer-BioNTech
-
2021-08-24
Dose 3 — Pfizer-BioNTech
-
2021-08-25
Registered in v-safe
-
2021-08-25
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-08-26
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Rash, not including the immediate area around the injection site · Be unable to work or attend schoolAdult check-in
-
2021-08-27
Survey response — days 1–6 daily, dose 3MedDRA: Vision blurred — Feeling: Good · Site: Pain · Headache, Muscle or body achesFree text: Blurry visionMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-28
- 2021-08-29
- 2021-08-30
- 2021-08-31
- 2021-09-07
-
2021-09-14
Survey response — day 21, dose 3MedDRA: Dysmenorrhoea, Heavy menstrual bleeding — Feeling: Good · Be unable to work or attend schoolFree text: Extremely painful menstrual cycle, bleeding for 10 days already, not normal for meMedDRA releases: 2024-11 · check-in free text available
- 2021-09-21
- 2021-09-28
- 2021-10-05
- 2021-11-23
- 2022-02-22
-
2022-09-13
Dose 4 — Pfizer-BioNTech
-
2022-09-14
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-09-16
Survey response — days 1–6 daily, dose 4MedDRA: Lactation insufficiency, Postpartum state — Feeling: Good · Headache, Joint pains, Fatigue or tirednessFree text: Transient Decrease in milk supply at 4 weeks post partumMedDRA releases: 2024-11 · check-in free text available
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-20
- 2022-09-27
- 2022-10-04
- 2022-10-11
- 2022-10-18
- 2022-10-27
- 2022-12-15
- 2023-03-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | No |
| 2 | 2021-04-21 | Pfizer-BioNTech | No |
| 3 | 2021-08-24 | Pfizer-BioNTech | No |
| 4 | 2022-09-13 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Blurry vision
Release 9 — day 21, dose 3
Symptoms: Extremely painful menstrual cycle, bleeding for 10 days already, not normal for me
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Transient Decrease in milk supply at 4 weeks post partum
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dysmenorrhoea | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SRO | Lactation insufficiency | · | · | ✓ |
| SRO | Postpartum state | · | · | ✓ |
| SRO | Vision blurred | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release